> "So marked is the effect of tobacco in relaxing the whole of the muscular system, that before the days of chloroform it was employed in surgical operation, in which it was necessary that the muscles should be perfectly cleaned."
>
> Sir Morell Mackenzie, in: The Tobacco Habit. Its History and Pathology. Herbert H. Tidswell, London, J&H Churchil, 1912.

Introduction {#sec1}
============

Cigarette smoking, the most important preventable cause of death worldwide, is strongly associated with the poor quality of life and health-care resources utilization. ([@ref155]) Physical inactivity, a common finding in smokers, has also been mechanistically linked to a plethora of nontransmissible diseases ([@ref154]; [@ref90]). There is, therefore, increasing awareness of the link between exercise intolerance and smoking ([@ref29]); moreover, the last decades witnessed a growing debate on the consequences of preclinical chronic obstructive pulmonary disease (COPD) -- the prototype of a smoking-related disease -- on clinical outcomes, including exercise intolerance ([@ref25]; [@ref28]; [@ref125]; [@ref140]).

In this context, reduced maximal and submaximal exercise tolerance and breathlessness on daily life (modified Medical Research Council dyspnea score, ≥2) have been described in a subgroup of smokers, even when they do not fulfill the extant physiological criteria for COPD ([@ref78]; [@ref102]; [@ref95]; [@ref123]; [@ref37], [@ref36]; [@ref153]; [@ref34]; [@ref100]; [@ref149]; [@ref47]) and they are not particularly sedentary ([@ref102]; [@ref47]). It is widely accepted that exercise intolerance is the final result of abnormalities in the complex interaction between large systems (mainly pulmonary and cardiocirculatory) which support O~2~ delivery to muscle mitochondria ([@ref23]; [@ref49]). In smokers, these abnormalities have been mainly ascribed to peripheral muscular factors ([@ref156],[@ref159]; [@ref33]; [@ref3]; [@ref115]). Oxygen (O~2~) transport disturbances \[including high blood carboxy-hemoglobin levels (HbCO); [@ref67]; [@ref98]; [@ref24]; [@ref14]\] and, potentially, cardiocirculatory abnormalities ([@ref51]; [@ref85]; [@ref18]; [@ref79]; [@ref145]; [@ref118]), and autonomic nervous system unbalance ([@ref81]; [@ref101]; [@ref68]). Of note, influential reviews on the topic ([@ref67]; [@ref65]) did not consider the modulatory effects of abnormalities that only recently have gained more attention, including early emphysema ([@ref135]; [@ref41]; [@ref59]; [@ref63]; [@ref105]; [@ref123]; [@ref4]; [@ref31]), pulmonary microvascular disease ([@ref113]; [@ref139]; [@ref63]; [@ref39]; [@ref138]; [@ref69]; [@ref126]; [@ref1], [@ref2]; [@ref134]), ventilatory inefficiency, ([@ref54]; [@ref37]; [@ref149]), gas exchange abnormalities ([@ref53], [@ref54], [@ref52]; [@ref35]), and left ventricular diastolic dysfunction ([@ref145]; [@ref119]; [@ref60]; [@ref160]; [@ref17]; [@ref142]; [@ref89]; [@ref112]).

As smoking duration is the main trigger for symptoms and risk for COPD, ([@ref95]; [@ref19]), it is conceivable that there is a continuum from reduced maximal exercise capacity at a young age toward exercise intolerance in middle-age and older smokers. In fact, some smokers do experience a larger-than-expected (by aging) decrease in maximal O~2~ consumption (V′O~2max~) (0.2--0.5 mL × min^−1^ × kg^−1^/year) ([@ref23]; [@ref129]; [@ref127]), an effect that might be, at least in part, genetically determined ([@ref130]). Thus, there is growing evidence in favor of derangements in the muscle-lung-heart axis ([@ref24]; [@ref59]; [@ref52]; [@ref33]; [@ref123]; [@ref89]; [@ref4]; [@ref134]; [@ref149]; [@ref14]) that may have sensory consequences and contribute to poor exercise tolerance in ever-smokers or former smokers without COPD ([Figure 1](#fig1){ref-type="fig"}, above). Overall, these derangements are followed by clinical traits increasingly described in the medical literature ([Figure 1](#fig1){ref-type="fig"}, below).

![Potential mechanisms underlying exercise (in)tolerance in symptomatic smokers and comparative main clinical abnormalities. Above, key respiratory, cardiocirculatory, and peripheral muscular (including mithocondrial) effects of chronic cigarette smoking are highlighted. Ventilation (V)/perfusion (Q) mismatch, in particular, may increase the ventilatory demand to exercise (*left graph*, reprinted with permission of the American Thoracic Society. Annals ATS. Vol. 14, No. Supplement_1, Jul 01, 2017) which, in association, with other source of ventilatory stimuli (and potential psychological/behavioral traits) increases exertional dyspnea at a given work rate (*right graph,* reproduced with permission of the ©ERS (2019): [@ref37]). Below, main characteristic clinical abnormalities of symptomatic (ex)smokers compared with asymptomatic smokers, healthy nonsmokers, COPD GOLD 1 and COPD GOLD 2. See text for further elaboration. PFT, pulmonary function tests; AO, airways obstruction; GOLD, global initiative for obstructive lung disease; COPD, chronic obstructive pulmonary disease; CO, carbon monoxide; DLco, lung diffusion capacity for CO; ATP, adenosine triphosphate; LVH, left ventricular hypertrophy; LVDD, left ventricular diastolic dysfunction; N/A, not applicable; mMRC, modified Medical Research Council; CAT, COPD Assessment Test; NE, not evaluated; CHF, chronic heart failure; SGRQ, St George's Respiratory Questionnaire; *V*′O~2peak~, peak oxygen consumption; ^\*^*p \<* 0.05 at similar work-rate.](fphys-10-00859-g001){#fig1}

The present review aims to succinctly summarize the recent advances in our knowledge on the effects of smoking on the muscle-lung-heart axis under the stress of exercise. Despite the fact that there is an acute-on-chronic effect of current smoking on these interactions, we will refrain from discussing the large body of clinical and experimental evidence showing the deleterious effects of acute tobacco smoking in nicotine-naive subjects ([@ref72]). Thus, we will focus on the chronic consequences of smoking on exercise intolerance from an integrative physiological perspective, giving special attention to the ancillary effects of aging, and physical inactivity.

Peripheral Muscular Abnormalities {#sec2}
=================================

Despite its relevance to exercise intolerance in subjects with COPD ([@ref5]; [@ref32]), there is a lack of in-depth discussion about the effects of smoking on the "muscle-mitochondria compartment" as a potential limiting factor in non-COPD smokers. In any case, reduced muscle strength and/or mass have been described in smokers ([@ref107]; [@ref158], [@ref157]; [@ref80]; [@ref128]; [@ref33]); of note, two meta-analyses suggested an independent effect (from physical inactivity) of cigarette smoking on reducing muscle mass ([@ref128]; [@ref141]). Conversely, chronic sympathetic nerve over-excitation induced by nicotine may counterbalance the potential deleterious effects of smoking on muscle mass ([@ref111]). Muscle wasting after chronic tobacco exposure in some smokers might be related to increased ubiquitin-mediated proteolysis ([@ref120]; [@ref96]; [@ref128]). In addition, smoking may inhibit anabolic pathways and protein synthesis in the quadriceps ([@ref33]; [@ref97]) (as extensively reviewed in [@ref33]). Current and former experimental data support changes in muscle fiber endotype toward a less oxidative profile ([@ref117]; [@ref107]; [@ref82], [@ref83]). However, reduced muscle capillarization remain questionable ([@ref107]; [@ref158]; [@ref115]). At the subcellular level, mitochondrial DNA might be damaged in smokers without COPD ([@ref44]).

These structural changes might negatively impact on muscle bioenergetics and metabolism. Spillover of inflammatory mediators produced by lung epithelial cells in response to smoking may reach the striated muscles with negative bioenergetic consequences ([@ref44]; [@ref97]). The mitochondrion, as important source of biochemical and thermal energy, is a key target for smoking toxicity, leading to reduced respiration, decreased ATP content, and increased production of free radicals in a dose- and time-dependent manner ([@ref114]; [@ref44]; [@ref97]). As a consequence, smokers may present with impaired oxidative phosphorylation (as extensively reviewed by [@ref44]). Other metabolic derangements with a potential to impact on physical performance include: An appreciable (10%) increase in energy expenditure at rest compared to nonsmoking subjects ([@ref66]), impaired sarcoplasmic reticulum Ca^++^ uptake in myofibres ([@ref115]), and impaired insulin-dependent glycogen recovery from exercise ([@ref71]). An early lactate threshold might be the final consequence of these bioenergetic derangements in association with chronically low levels of muscle activation, i.e., sedentarism ([@ref103]; [@ref86]).

However, only a few studies showed reduced peripheral muscle strength ([@ref80]) or reduced fatigue resistance to electrical stimulation under controlled conditions in smokers compared with nonsmokers with similar physical (in)activity scores ([@ref158],[@ref159]). In fact, this is a major confounder as several studies failed to show lower scores of peripheral muscle fatigue ([@ref117]; [@ref84]) or force generation ([@ref158],[@ref159]) in smokers when compared to controls paired by self-reported physical activity. Diminished resistance to fatigue in smokers was demonstrated using effort-independent techniques, such as electrically evoked muscle contractions ([@ref159]) and CO inhalation ([@ref108]). Interestingly, however, nicotine may also have ergogenic effects through augmented release of adrenaline and enhanced performance of fast-twitch muscle fibers ([@ref72]). Thus, any potential increase in muscle fatigability in smokers might be compensated by the central excitatory actions of nicotine leading to preserved time to task failure compared to equally sedentary controls ([@ref117]; [@ref84]).

Cardiocirculatory Abnormalities {#sec3}
===============================

Large population-based studies found subtle cardiac structure and function abnormalities, which could be mechanistically related to smoking ([@ref51]; [@ref85]; [@ref18]; [@ref119]; [@ref112]); of note, some of these studies suggested increased left ventricular mass and chronotropic incompetence during exercise ([@ref51]; [@ref85]; [@ref119]). Key abnormalities found in chronic smokers include increased autonomic activity ([@ref81]; [@ref85]; [@ref101]; [@ref68]), elevated catecholamine levels ([@ref87]; [@ref81]; [@ref27]), acute and chronic rest systemic arterial hypertension, largely related with arterial stiffness and secondary to tobacco induced endothelial dysfunction ([@ref136]), altered exercise heart rate-systolic blood pressure product ([@ref118]), left ventricular diastolic dysfunction ([@ref145]; [@ref119]; [@ref60]; [@ref160]; [@ref17]; [@ref89]; [@ref112]), and direct myocardial depression due to CO in heavy smokers ([@ref24]). Of note, despite the fact that exposure to tobacco smoke is a strong risk factor for pulmonary hypertension and chronic thromboembolic disease, ([@ref137]; [@ref152]; [@ref74]), there is a lack of studies addressing potential abnormalities in pulmonary vascular conductance during exercise in symptomatic non-COPD smokers. Isolated left ventricular diastolic dysfunction was previously associated with reduced exercise capacity in some populations ([@ref50]; [@ref13]; [@ref57]). However, there was only a weak relationship between left ventricular dysfunction and tolerance to stress exercise testing in smokers without COPD ([@ref57]). Of note, we could not confirm these findings in patients with COPD ([@ref110]). Downregulation of β-adrenoceptors ([@ref87]) and blunted heart rate during exercise are described maladaptations to chronic smoking ([@ref85]). Conversely, resting heart rate is commonly increased, likely due to the combined effects of: the pharmacological action of nicotine ([@ref146]), increased circulating levels of catecholamine ([@ref87]; [@ref81]; [@ref27]), modulatory effects on baroreflex function ([@ref18]; [@ref118]; [@ref101]) and chronic reduction in the vagal drive ([@ref101]). Thus, resting tachycardia, in association with myocardium stiffness ([@ref51]) and diastolic dysfunction, ([@ref145]; [@ref119]; [@ref60]; [@ref160]; [@ref142]) may critically interfere with the ideal diastolic time-pressure product necessary to optimize left ventricular filling ([@ref45]). In fact, O~2~-pulse -- a surrogate for stroke volume under certain conditions -- was found lower during submaximal exercise in smokers compared to nonsmoker controls ([@ref79]). In addition, [@ref75] using near-infrared spectroscopy showed increased O~2~ extraction at the right vastus lateralis during incremental exercise testing in the majority of "healthy" smokers compared to nonsmokers. This is in line with potential decrements in muscle O~2~ delivery caused by central derangements.

Muscle hyperemia on exercise due to microcirculatory adaptations is highly dependent on shear stress to induce nitric oxide (NO) release, i.e., endothelium-dependent vascular relaxation ([@ref56]). Smoking-induced oxidative stress is a trigger for a generalized vascular inflammation ([@ref55]; [@ref97]), the latter being associated with: lower expression of endothelial NO synthetase, increased expression of TNF-α, IL-6, and IL-1β ([@ref55]), downregulation of IL-10 ([@ref6]), increased adhesion of inflammatory cells stimulated by ICAM-1 and IL-8 ([@ref97]) and, ultimately, disruption of endothelial integrity as a protective barrier ([@ref55]). These abnormalities may impair the endothelium-dependent hyperemic response to exercise ([@ref16]) and increase arterial vascular resistance ([@ref33]). It is noteworthy that impairment in endothelium-dependent hyperemia has been associated with lower exercise tolerance in smokers ([@ref64]; [@ref106]).

In addition to these cardiocirculatory abnormalities, muscle O~2~ delivery on exercise may be impaired due to the deleterious consequences of increased (HbCO) as CO has a \~ 250 higher affinity to Hb compared to O~2~ ([@ref98]; [@ref75]; [@ref73]). Smokers may show up to 9% HbCO leading to decrements in O~2~ content similar to those found in hypoxemic patients ([@ref33]). High levels (two to three times normal range) can persist up to 90 min after smoking ([@ref70]). Accordingly, several animal- and human-based studies demonstrated the deleterious effects of HbCO on submaximal ([@ref98]; [@ref73]) and maximal exercise capacity ([@ref148]; [@ref9]; [@ref10]; [@ref77]). These findings should be tempered with others which failed to show alterations in endurance ([@ref146]; [@ref131]). These discrepancies might be linked to the large inter-study variability on CO exposure or individual differences in CO clearance ([@ref161]). Of note, exercise on room air accelerates CO elimination compared to resting and moderate exercise is as effective as breathing 100% O~2~ at rest on this regard ([@ref161]). The deleterious consequences of high (HbCO) might be particularly important in the presence of comorbidities: low-dose inhaled CO ([@ref8]) and nicotine patch in substitution to smoking ([@ref99]) have been implicated in lower exercise capacity seen in smokers with ischemic heart disease.

Respiratory Abnormalities {#sec4}
=========================

Spirometrically occult airways and lung parenchymal disease, pulmonary microvascular disease, gas exchange, and respiratory muscle abnormalities could potentially contribute to decrease exercise tolerance due to exertional dyspnea in symptomatic smokers ([@ref62]; [@ref39]; [@ref124]; [@ref37]; [@ref153]; [@ref20]; [@ref100]; [@ref22]). Airway disease with chronic bronchitic symptoms is largely recognized in smokers without COPD ([@ref124]; [@ref153]; [@ref100]). It is conceivable that dysfunction in cystic fibrosis transmembrane conductance regulator (CFTR) might be mechanistically involved in the chronic bronchitis seen in some smokers without COPD, thereby leading to a clinical phenotype similar to mild cystic fibrosis ([@ref122]). There is limited evidence that these symptoms might be related to reduced daily physical activity, independent of age and sex ([@ref153]). In a large observational study (SPIROMICS) ([@ref100]), imaging evidence of initial airway disease, more frequent exacerbations, and poorer exercise tolerance were found in symptomatic current or former smokers with normal pulmonary function compared to nonsmokers and asymptomatic smokers with airflow limitation. Of note, about 50% of smokers without airway obstruction have symptoms such as dyspnea ([@ref123]). Symptomatic smokers with dyspnea and preserved lung function may present with abnormally increased airway wall thickening on high-resolution computerized tomography scans (HRCT), suggesting early involvement of the small airways ([@ref123]; [@ref153]). Interestingly, although airway wall thickening decreases with higher age, smokers maintain higher airway wall thickening throughout aging ([@ref144]). In fact, increased closure volume of the small airways and high peripheral airway resistance by impulse oscillometry might be seen in smokers with dyspnea on exertion ([@ref34]). Incipient/mild emphysema can also be found in heavy smokers with preserved spirometry ([@ref123]), being occasionally associated with poor exercise tolerance and increased self-reported activity limitation on daily life ([@ref123]; [@ref4]). [@ref76] and [@ref121] using advanced magnetic resonance imaging (MRI) identified substantial ventilation inhomogeneity in ex-smokers without airflow limitation; of note, this was spatially coincident with incipient/mild emphysema demonstrated on CT.

How those abnormalities could be mechanistically linked to activity-related dyspnea in smokers? Heightened awareness of increased efferent activity from bulbopontine and cortical motor centers to the inspiratory muscles are closely linked to exertional dyspnea ([@ref150]). [@ref37] found that higher fractional inspiratory neural drive to the diaphragm in smokers without COPD was secondary to compensatory increases in inspiratory diaphragm electromyographic activity to overcome increased airways resistance and lower maximal activation ([Figure 2](#fig2){ref-type="fig"}). Severe leg discomfort also contributed to exercise intolerance in this study: peripheral muscle weakness ([@ref33]), greater motor command output ([@ref150]; [@ref37]), and high perceived effort (relative to maximum) ([@ref48]) could be mechanistically involved in these findings (see also Peripheral Muscular Abnormalities section). Also, there are limited data pointing out for attenuated peripheral metaboreflex in non-COPD smokers ([@ref500]). Of note, no study to date has specifically investigated whether symptomatic smokers without COPD may present with impaired respiratory muscle metaboreflex. If this is experimentally demonstrated, such results would provide the basis for additional studies exploring the hypothesis of blood flow redistribution from the locomotor muscles to the overburden respiratory muscles in these subjects ([@ref116]).

![Diaphragm electromyography (EMG~di~, **A** and **C**), transdiaphragmatic pressure (*P*~di~, **B,D** and **E**), and oesophageal pressure (*P*~oes~, **F**) are shown during incremental cycle exercise in smokers without chronic obstructive pulmonary disease (COPD) and age-matched healthy controls. Dynamic maximal measurements during inspiratory capacity (IC) manoeuvres are also shown. (Reproduced with permission of the ©ERS 2019: [@ref37]). Data are presented as mean ± SEM. ^\*^*p* \< 0.05 smokers without COPD versus healthy controls at rest, at standardized work rates or at peak exercise. Insp, inspiratory; Exp, expiratory.](fphys-10-00859-g002){#fig2}

It is also plausible that increased chemo-stimulation as a result of higher physiological dead space (increased V′E/V′CO~2~, ventilatory inefficiency) contributes to a higher inspiratory neural drive during tidal breathing in some smokers ([@ref37]; [@ref151]). Increased V′E/V′CO~2~, likely reflecting high VD/VT, was found in smokers with only mild spirometric abnormalities ([@ref36],[@ref38]) and smokers with low lung diffusion capacity for CO ([@ref149]). Importantly, a large populational study found that, after careful control for confounders, chronic cigarette smoking was associated with increased alveolar-arterial gradient and dead space on exercise ([@ref53], [@ref52]). Despite the absence of overt hypoxemia, there is evidence that smokers without COPD may present with large carotid bodies ([@ref30]; [@ref143]), potentially increasing peripheral chemosensitivity and the inordinary ventilatory response to exercise found in some smokers. In any case, high dead space might reflect enlarged areas of increased ventilation/perfusion relationship independent of emphysema, i.e., early microvascular disease ([@ref63]; [@ref39]; [@ref134]). Another piece of indirect evidence suggesting early pulmonary microvascular disease is the common finding of out-of-proportion decrease in DLco relative to macroscopic emphysema burden in symptomatic smokers ([@ref76]). It is also noteworthy that, at least in smoking rodent models, pulmonary vascular changes with neomuscularization of precapillary arteries may precede the development of emphysema ([@ref43], [@ref42]) -- as proposed by Liebow six decades ago ([@ref92]). Moreover, significant remodeling of the pulmonary arteries has been observed in heavy smokers ([@ref132]). Smoking has been associated with endothelial ([@ref139]; [@ref138]) and epithelial damage ([@ref97]): cigarette smoke products may cause pulmonary vascular remodeling through either a direct effect on endothelial cells or an inflammatory mechanism ([@ref16]; [@ref6]; [@ref97]). Indeed, elevated amounts of circulating endothelial microparticles were found in smokers ([@ref11]; [@ref94]; [@ref104]).

Clinically, there is growing evidence that a subset of non-COPD smokers present with imaging evidence of microvascular pruning or constriction ([@ref69]; [@ref133]) and functional abnormalities consistent with the areas of increased ventilation-perfusion relationship ([@ref52]; [@ref126]; [@ref20]). Interestingly, ventilatory inefficiency has been associated with impaired flow-mediated dilation in smokers, supporting a generalized vasculopathy ([@ref54]). Impaired ability in recruiting pulmonary vessels during exercise has been demonstrated in light smokers ([@ref126]) or second-hand smokers ([@ref7]). Moreover, a large population-based study showed the presence of pulmonary artery enlargement on HRCT in smokers without COPD ([@ref93]). Overall, compensatory increases in minute ventilation are likely useful to maintain alveolar ventilation and arterial blood gas homeostasis in symptomatic smokers but this might hasten dynamic mechanical constraints thereby contributing to dyspnea and exercise intolerance. ([@ref37]; [@ref34]) These physiological considerations should be tempered with the observation that smokers have two to four times more panic-depression and anxiety disturbances compared to controls ([@ref163]; [@ref109]; [@ref40]). These abnormalities are associated with a chaotic breathing pattern and hyperventilation sindromes ([@ref21]; [@ref12]), and accordingly, contemporary models of fatigue point out to complex interactions between physiological activity and psychological state ([@ref58]). Hence, such complex "coordinated deadaptation"([@ref23]) in symptomatic smokers might lead to perceived fatigability (sensations about fatigue) and performance fatigability (incapacity of the neuromuscular system to meet the requirements of a given task) ([@ref171]). Thus, objective and subjective mechanisms may dynamically interact and prompt early exercise cessation in susceptible smokers.

Finally, there is limited evidence that some smokers may present with reduced inspiratory muscle strength ([@ref46]; [@ref22]) and endurance though this is not a universal finding ([@ref37]). Owing to exquisitive sensitivity of the diaphragm to hypoxia ([@ref162]; [@ref91]), low-grade inflammation ([@ref61]), and oxidative stress ([@ref88]; [@ref15]), it remains possible that it might suffer the consequences of chronic smoking. During exercise, O~2~ delivery to the respiratory muscles might be impaired in some smokers -- similarly to what has been demonstrated in the peripheral muscles in non-COPD smokers -- at very high levels of ventilation ([@ref75]). In the above-mentioned study by [@ref37], the authors found that the rib cage and accessory muscles contributed to a greater extent to meet a heightened ventilatory response to exercise in symptomatic smokers. This might constitute a useful strategy to spare a mechanically stressed diaphragm. In view of the experimental data supporting diaphragm wasting secondary to tobacco exposure, ([@ref26]; [@ref147]) increased ventilatory demands during exercise might overload the diaphragm, thereby contributing to exertional dyspnea.

Conclusions {#sec5}
===========

Multiple interrelated mechanisms may decrease the ability of smokers without COPD to face the challenges brought by physical exercise. In fact, the stress of exercise constitutes a physiologically elegant -- and clinically relevant -- model to expose the deleterious effects of oxidative stress, pro-inflammatory status, sustained high-circulating nicotine levels, low O~2~ content, and high carbon monoxide on human health well before they are apparent at rest. Although physical inactivity and, potentially, specific psychological traits are major confounders, there seems to exist a subset of smokers who are particularly intolerant to exertion. Complex and yet poorly understood interactions among cardiopulmonary and muscular abnormalities might underlie this specific phenotype of "symptomatic smokers on exertion." A deeper understanding of the systemic effects of smoking in subjects who did not (yet) show evidences of devastating smoking related diseases, such as COPD and ischemic heart disease, might prove instrumental to fight their ever-growing burden.
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